Cargando…
Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review
The landscape for medical treatment of lung cancer has irreversibly changed since the development of immuno-oncology (IO). Yet, while immune checkpoint blockade (ICB) revealed that T lymphocytes play a major role in lung cancer, the precise dynamic of innate and adaptive immune cells induced by anti...
Autores principales: | Rochigneux, Philippe, Garcia, Alejandro J., Chanez, Brice, Madroszyk, Anne, Olive, Daniel, Garon, Edward B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327092/ https://www.ncbi.nlm.nih.gov/pubmed/32670271 http://dx.doi.org/10.3389/fimmu.2020.01036 |
Ejemplares similares
-
Celiac Disease After Administration of Immune Checkpoint Inhibitors: A Case Report
por: Leblanc, Julie, et al.
Publicado: (2021) -
Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2021) -
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records
por: Beaufils, Mathilde, et al.
Publicado: (2023) -
Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors
por: Faure, Marjorie, et al.
Publicado: (2018) -
Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials
por: Rochigneux, Philippe, et al.
Publicado: (2021)